Design, Synthesis, and Structure—Activity Relationships of a Series of 2-Ar-8-methyl-5-alkylaminoquinolines as Novel CRF1 Receptor Antagonists.

2013 
Novel compounds (VI) are identified as orally active corticotropin-releasing factor 1 (CRF1) receptor antagonists.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    1
    References
    0
    Citations
    NaN
    KQI
    []